Comprehensive approach to high-resolution KIR typing

Human Immunology

Volumn 68, Issue 9, 2007, Pages 789-796

  Lebedeva, Tatiana V ^a   Ohashi, Marina ^a   Zannelli, Georgia ^a   Cullen, Rebecca ^b   Yu, Neng ^a  

^a AMERICAN RED CROSS BLOOD SERVICES   (United States)

^b NATIONAL MARROW DONOR PROGRAM   (United States)

Author keywords

KIR; Sequence based typing; Sequence specific oligonucleotides (SSO); Sequence specific primer (SSP)

Indexed keywords

IMMUNOGLOBULIN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ALLELE; ARTICLE; BONE MARROW; CAUCASIAN; CONTROLLED STUDY; CYTOPLASM; EXON; EXTRACELLULAR SPACE; GENE AMPLIFICATION; GENE LOCUS; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN;

HUMANS; IMMUNOPHENOTYPING; MULTIGENE FAMILY; PILOT PROJECTS; RECEPTORS, IMMUNOLOGIC; RETROSPECTIVE STUDIES;

EID: 34548487561     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2007.07.002     Document Type: Article

References (28)

1. Rajagopalan S., and Long E.O. Understanding how combinations of HLA and KIR genes influence disease. J Exp Med 201 (2005) 1025
2. Nakajima T., Goek O., Zhang X., Kopecky S.L., Frye R.L., Goronzy J.J., and Weyland C.M. De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndrome. Circ Res 93 (2003) 106
3. Nelson G.W., Martin M.P., Gladman D., Wade J., Trowsdale J., and Carrington M. Heterozygote advantage in autoimmune disease: Hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 173 (2004) 4273
4. Handgretinger R., Geiselhart A., Moris A., Grau R., Teuffel O., Bethge W., et al. Pure red-cell aplasia association with clonal expansion of granular lymphocytes expression killer-cell inhibitory receptors. N Engl J Med 340 (1999) 278
5. Ruggeri L., Capanni M., Urbani E., Perruccio K., Shlomchik W.D., Tosti A., et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295 (2002) 2097
6. Hsu K.C., Keever-Taylor C.A., Wilton A., Pinto C., Heller G., Arkun K., et al. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood 105 (2005) 4878
7. Verheyden S., Schots R., Duquet W., and Demanet C.A. A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation. Leukemia 19 (2005) 1446
8. Giebel S., Locatelli F., Lamparelli T., Velardi A., Davies S., Frumento G., et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 102 (2003) 814
9. Marsh S.G., Parham P., Dupont B., Geraghty D.E., Trowsdale J., Middleton D., et al. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Hum Immunol 64 (2003) 648
10. Long E.O., and Rajagopalan S. HLA class I recognition by killer cell Ig-like receptor. Semin Immunol 12 (2000) 101
11. Hansasuta P., Dong H., Thananchai M., Weekes M., Willberg C., Aldemir H., et al. Recognition of HLA-A3 and HLA-A11 by KIR3Dl2 is peptide-specific. Eur J Immunol 34 (2004) 1673
12. Biassoni R., Pessino A., Malaspina C., Cantoni C., Bottino C., Sivori S., et al. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur J Immunol 27 (1997) 3096
13. Winter C.C., Gumperz P., Parham E.O., Long E.O., and Wagtmann N. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol 161 (1998) 571
14. Vales-Gomez M., Erskine R.A., Deacon M.P., Strominger J.L., and Reyburn H.T. The role of zinc in the binding of killer cell Ig-like receptors to class I MHC proteins. Proc Natl Acad Sci USA 98 (2001) 1734
15. Stainer N.K., and Hurley C.K. KIR3DL3 allelic diversity: Six new alleles exhibit both conservative and non-conservative substitutions. Tissue Antigens 67 (2006) 277
16. Jones D.C., Hiby S.E., Moffett A., Trowsdale J., and Young N.T. Nature of allelic sequence polymorphism at the KIR3DL3 locus. Immunogenetics 58 (2006) 614
17. Trundley A.E., Hiby S.E., Chang C., Sharkey A.M., Santourlidis S., Uhrberg M., et al. Molecular characterization of KIR3DL3. Immunogenetics 57 (2006) 904
18. Hedge R.S., and Bernstain H.D. The surprising complexity of signal sequences. Trends Biochem Sci 31 (2006) 563
19. Lanier L.L., Corliss B.C., Wu J., Leong C., and Phillips J.H. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391 (1998) 703
20. Burshlyn D.N., Scharenberg A.M., Wagtmann N., Rajagopalan S., Berrada K., Yi T., et al. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 4 (1996) 77
21. Colonna M., Borselino G., Falco M., Ferrara G.B., and Strominger J.L. HLA-C is the inhibitory ligand that determines dominant resistance by lysis by NK-1 and NK-2-specific natural killer cells. Proc Natl Acad Sci USA 90 (1993) 12000
22. Wagtmann N., Rajagopalan S., Winter C.C., Peruzzi M., and Long E.O. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 3 (1995) 801
23. Cella M., Longo A., Ferrara G.B., Strominger J.L., and Colonna M. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med 180 (1994) 1235
24. Gumperz J.E., Litwin V., Phillips J.H., Lanier L.L., and Parham P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 181 (1995) 1133
25. Dohring C., Scheidegger D., Samaridis J., Cella M., and Colonna M. A human killer inhibitory receptor specific for HLA-A. J Immunol 156 (1996) 3098
26. Kikuchi-Maki A., Catina T.L., and Campbell K.S. Cutting edge: KIR2DL4 transduces signals into human NK cells through association with Fc receptor gamma protein. J Immunol 174 (2005) 3859
27. Rajagopalan S., and Long E.O. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 189 (1999) 1093
28. Yawata M., Yawata N., Draghi M., Little A.M., Partheniou F., and Parham P. Roles for HLA and KIR polymorphism in natural killer cell repertoire selection and modulation of effector function. J Exp Med 203 (2006) 633